Innodata director sells 20,000 shares after option exercise
INNODATA INC director Louise C. Forlenza reported a mix of option exercises and share sales.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
INNODATA INC director Louise C. Forlenza reported a mix of option exercises and share sales. She exercised stock options for 20,000 shares of common stock at a $1.24 exercise price on May 19 and 20, 2026, then sold 20,000 shares in open-market transactions at prices generally in the $86–$95 range. After these trades, she continues to hold 3,943 restricted stock units, which will vest in full on the earlier of June 5, 2026 or Innodata’s 2026 annual meeting, and will then be settled in common shares. A footnote states the sales were made for personal investment, retirement planning, and portfolio diversification purposes.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 15,000 | $1.24 | $19K |
| Sale | Common Stock | 5,000 | $93.02 | $465K |
| Sale | Common Stock | 5,000 | $90.07 | $450K |
| Sale | Common Stock | 4,998 | $93.89 | $469K |
| Sale | Common Stock | 2 | $94.76 | $189.52 |
| Exercise | Stock Option (Right to Buy) | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 5,000 | $1.24 | $6K |
| Sale | Common Stock | 5,000 | $86.10 | $431K |
Footnotes (7)
- F1. Includes 3,943 restricted stock units ("RSUs") that will vest 100% on the earlier to occur of (i) June 5, 2026; and (ii) the date of Innodata Inc.'s 2026 annual meeting of stockholders and will be settled into shares of Innodata's common stock upon vesting.
- F2. The sale of the shares reported in Column 4 was made as part of the reporting person's personal investment and financial planning needs, including for individual retirement planning and portfolio diversification purposes.
- F3. This transaction was executed in multiple trades at prices ranging from $86 to $86.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. This transaction was executed in multiple trades at prices ranging from $92.9 to $93.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. This transaction was executed in multiple trades at prices ranging from $90 to $90.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6. This transaction was executed in multiple trades at prices ranging from $93.54 to $94.44. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F7. This stock option became fully vested and exercisable on August 1, 2019.
Key Figures
Key Terms
restricted stock units ("RSUs") financial
open-market sale financial
weighted average sale price financial
Stock Option (Right to Buy) financial
derivative exercise/conversion financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock options did Louise C. Forlenza exercise in this Innodata (INOD) Form 4?
What Innodata (INOD) equity does Louise C. Forlenza still hold after these transactions?
Why does the Innodata (INOD) Form 4 say the sales were made by Louise C. Forlenza?
How are weighted-average prices described in this Innodata (INOD) Form 4 filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.